Small cell lung cancer in a young non-smoking woman: A distinct disease profile highlighting the need for molecular characterization

Small cell lung cancer (SCLC) is strongly associated with smoking, and its occurrence in non-smoking patients, particularly in young women, is rare and poorly understood. We report a 39-year-old non-smoking female who presented with extensive-stage SCLC with liver and brain metastases. No history of tobacco exposure, chronic illness, or familial cancer predisposition was found. The patient was treated with carboplatin and etoposide, followed by cranial radiotherapy, and remains under treatment. Non-smoking SCLC represents a distinct and underexplored subset with rapid disease progression, limited therapeutic options, and high mortality. Further genomic profiling studies are needed to identify potential driver alterations and guide personalized therapy in this rare and aggressive cancer subtype.

Authors

Institutions

Publication Details

Journal
Journal of Bionic Memory
Published
2025-11-02
DOI
https://doi.org/10.53545/jbm.2025.48
Primary Topic
Lung Cancer Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Small cell lung cancer in a young non-smoking woman: A distinct disease profile highlighting the need for molecular characterization

M. Özcan Ersoy
Journal of Bionic Memory
Lung Cancer Research Studies
article

Small cell lung cancer in a young non-smoking woman: A distinct disease profile highlighting the need for molecular characterization

M. Özcan Ersoy
article en

Abstract

Small cell lung cancer (SCLC) is strongly associated with smoking, and its occurrence in non-smoking patients, particularly in young women, is rare and poorly understood. We report a 39-year-old non-smoking female who presented with extensive-stage SCLC with liver and brain metastases. No history of tobacco exposure, chronic illness, or familial cancer predisposition was found. The patient was treated with carboplatin and etoposide, followed by cranial radiotherapy, and remains under treatment. Non-smoking SCLC represents a distinct and underexplored subset with rapid disease progression, limited therapeutic options, and high mortality. Further genomic profiling studies are needed to identify potential driver alterations and guide personalized therapy in this rare and aggressive cancer subtype.

Journal of Bionic Memory
Kütahya Dumlupınar Üniversitesi (TR), Sağlık Bilimleri Üniversitesi (TR)
Good health and well-being
Openalex Percentile: Top 29%
Lung Cancer Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.